 Announced Earlier Today-Notice Received from ANDA Filer for FIRDAPSE CORAL GABLES, Fla., Jan. 23, 2023 GLOBE NEWSWIRE Catalyst Pharmaceuticals, Inc. Catalyst NASDAQ: CPRX, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today commented on the FDAs notice setting forth its position on Orphan Drug Exclusivity ... The post Catalyst Pharmaceuticals Comments on FDAs Announcement... 